April 3, 2022
Video

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

09:17

C. Michael Gibson and Milind Desai discuss the VALOR-HCM results presented at ACC 2022.

Partner Content

Explore All